Epigallocatechin-3-gallate augments the therapeutic effects of benzo[a]pyrene-mediated lung carcinogenesis.

about

Epigallocatechin-3-gallate augments the therapeutic effects of benzo[a]pyrene-mediated lung carcinogenesis.

Item

http://www.wikidata.org/entity/Q38714404

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Epigallocatechin-3-gallate aug ...... -mediated lung carcinogenesis.

@en

type

Item

label

Epigallocatechin-3-gallate aug ...... -mediated lung carcinogenesis.

@en

prefLabel

Epigallocatechin-3-gallate aug ...... -mediated lung carcinogenesis.

@en

P1476

Epigallocatechin-3-gallate aug ...... -mediated lung carcinogenesis.

@en

P2093

Meghan M Cromie

http://www.w3.org/2001/XMLSchema#string

Weimin Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapeutic sensitization of leptomycin B resistant lung cancer cells by pretreatment with doxorubicin

First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

The protein kinase B/Akt signalling pathway in human malignancy

Correlations between RNA and protein expression profiles in 23 human cell lines.

Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases.

Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.

Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells.

P304

529-539

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BIOF.1355

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zhongwei Liu

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28247504

http://www.w3.org/2001/XMLSchema#string

P932

5554095

http://www.w3.org/2001/XMLSchema#string

Epigallocatechin-3-gallate augments the therapeutic effects of benzo[a]pyrene-mediated lung carcinogenesis.

about

Epigallocatechin-3-gallate augments the therapeutic effects of benzo[a]pyrene-mediated lung carcinogenesis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932